Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | DRD3 | P35462 | 2/20 | 0.48 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.48 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.48 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.44 |
| ▸ | APP | P05067 | 4/20 | 0.44 |
| ▸ | SNCA | P37840 | 4/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NR2E1 | Q9Y466 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | RXRA | P19793 | 5/20 | 0.42 |
| ▸ | RARA | P10276 | 5/20 | 0.42 |
| ▸ | RARB | P10826 | 5/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6896312 | 1.00 | CYP1A2 (0.53) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL22125376 | 0.86 | CYP1A2 (0.51) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL22125377 | 0.86 | CYP1A2 (0.51) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL7898750 | 0.85 | CYP1A2 (0.57) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL7898751 | 0.85 | CYP1A2 (0.57) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL11065288 | 0.83 | ALDH1A1 (0.68) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL11065284 | 0.83 | ALDH1A1 (0.68) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL5268321 | 0.79 | CYP1A2 (0.45) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL5268328 | 0.79 | CYP1A2 (0.45) | CYP1A2ALDH1A1PTGS1LMNADRD3 | |
| SCHEMBL5268330 | 0.79 | CYP1A2 (0.45) | CYP1A2ALDH1A1PTGS1LMNADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110304990-B | Green process for producing vinyl beta-ionol | 南京瑞鼎生物医药有限公司 | 2022-10-25 | — | — | CN | claimed |
| CN-109651150-B | Method for preparing vitamin A acetate | 万华化学集团股份有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-6828468-B2 | By base-catalyzed monoethynylation of a ketone in liquid ammonia | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-07 | — | — | US | claimed |
| US-20020183565-A1 | Preparation of higher alpha, beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-05 | — | — | US | claimed |
| EP-1256560-A2 | Process for the preparation of higher alpha,beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-13 | — | — | EP | claimed |
| JP-8311089-A | — | — | None | — | — | JP | disclosed |
| WO-2024133318-A1 | NEW INTERMEDIATE FOR BETA-CAROTENE SYNTHESIS | DSM IP ASSETS B.V. (NL) | 2024-06-27 | — | — | WO | disclosed |
| CN-116712755-A | Method for separating and purifying phosphonate, phosphonate and vitamin A acetate prepared by same | 江西天新药业股份有限公司 | 2023-09-08 | — | — | CN | disclosed |
| CN-110304990-B | Green process for producing vinyl beta-ionol | 南京瑞鼎生物医药有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-110304990-B | Green process for producing vinyl beta-ionol | 南京瑞鼎生物医药有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-110304990-B | Green process for producing vinyl beta-ionol | 南京瑞鼎生物医药有限公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-109651150-B | Method for preparing vitamin A acetate | 万华化学集团股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20080207946-A1 | PROCESS FOR PREPARATION OF HIGHLY PURE ISOTRETINOIN | IPCA LABORATORIES LIMITED (IN) | 2008-08-28 | — | — | US | disclosed |
| US-20080207946-A1 | PROCESS FOR PREPARATION OF HIGHLY PURE ISOTRETINOIN | IPCA LABORATORIES LIMITED (IN) | 2008-08-28 | — | — | US | disclosed |
| US-20070082950-A1 | Method for producing vitamin a acetate | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20070082950-A1 | Method for producing vitamin a acetate | BASF AKTIENGESELLSCHAFT (DE) | 2007-04-12 | — | — | US | disclosed |
| US-6828468-B2 | By base-catalyzed monoethynylation of a ketone in liquid ammonia | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-07 | — | — | US | disclosed |
| US-20020183565-A1 | Preparation of higher alpha, beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-05 | — | — | US | disclosed |
| EP-1256560-A2 | Process for the preparation of higher alpha,beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-13 | — | — | EP | disclosed |
| JP-H08311089-A | PRODUCTION OF PHOSPHONATE COMPOUND | TAKEDA CHEM IND LTD | 1996-11-26 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070082950-A1 | Method for producing vitamin a acetate | TTPA, ADH7, VNN1 | CYP1A2 270/4885ALDH1A1 305/4885PTGS1 1348/4885 |
| US-20020183565-A1 | Preparation of higher alpha, beta-unsaturated alcohols | ADH1C, CHKB, PDK3 | CYP1A2 423/4885ALDH1A1 121/4885PTGS1 1011/4885 |
| US-20080207946-A1 | PROCESS FOR PREPARATION OF HIGHLY PURE ISOTRETINOIN | RARA, RARB, RARG | CYP1A2 145/4885ALDH1A1 838/4885PTGS1 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.